The CAD $2.6 million pre-seed financing round included support from GlycoNet’s Kickstart Program.
Catégorie : News Releases
Sussex Research and GlycoNet-Supported Startup 48Hour Discovery Announce Strategic Partnership
Together, they will develop and commercialize game-changing Liquid Glycan Array (LiGA) reagents designed to enable high-throughput, multiplex profiling of protein-glycan interactions on cell surfaces.
Le rôle des sucres dans l’avenir de la médecine et de l’agriculture
This article highlights some of the ways that Canadian researchers are using glycomics to drive medical breakthroughs and more sustainable
Lighting Up Breast Cancer and Canada’s Path From Lab to Clinic
A new sugar-based breast-cancer imaging agent set to enter human trials highlights opportunities to streamline the path from lab to clinic here at home.
GlycoNet releases its 2022-2023 Corporate Report
The report encapsulates a comprehensive overview of the network’s achievements, breakthroughs, and collaborations in the field of glycomics throughout the past year.
Within the report, readers will gain insight into the cutting-edge research and advancements made by GlycoNet, a collaborative effort involving scientists, researchers, and experts from academia, industry, and government institutions. It delves into the pioneering discoveries in glycobiology, highlighting the innovative applications and technologies that have emerged within the network.
A Tour of the GlycoNet facilities with the Honourable Randy Boissonnault
A significant gathering of researchers, industry experts, and rising stars in glycomics recently took place in Edmonton, Alberta with the Honourable Randy Boissonnault, focusing on advancements and current trends in the field.
GlycoNet Scientific Director and PlantForm awarded grant to enable commercial-scale production of protein drugs
The NSERC Alliance Grant will support the advancement of glycoengineering technology for plant-derived proteins.